Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is -14.91% vs -63.43% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -242.94% vs -57.16% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -505.20% vs -85.81% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -69.23% vs 225.00% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Sunflower Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -42.19% vs -2.55% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -14.91% vs -63.43% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -661.67% vs -61.39% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -242.94% vs -57.16% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -327.97% vs -31.67% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -505.20% vs -85.81% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -42.86% vs 600.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -69.23% vs 225.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






